Trusted Data for Pharma and Life Sciences

Pharma and life sciences organizations operate in highly complex environments where data must be reliable, traceable and accessible across the entire value chain. APGAR helps pharmaceutical, biotech and medtech organizations build trusted data foundations, strengthen governance and connect information across research, clinical, manufacturing, supply chain and commercial operations. Our approach combines Data and AI strategy, governance, architecture, Master Data Management and intelligent solutions to transform fragmented information into a strategic and compliant business asset. APGAR identifies Pharma & Life Sciences as one of its six priority sectors, covering pharmaceutical, biotech, medtech and broader life sciences organizations.

From fragmented data to trusted life sciences intelligence.

pharma and life science sectorial picture 3

Build a reliable data foundation across the value chain

Pharma and life sciences data is often distributed across research platforms, clinical systems, laboratories, manufacturing applications, ERP solutions and commercial tools.

Without consistent definitions and governance, organizations may struggle to connect information, maintain data quality and provide teams with a reliable view of products, compounds, studies, sites, suppliers and healthcare stakeholders.

APGAR helps organizations establish a common data foundation by aligning business definitions, ownership, governance processes and technology. This creates trusted and reusable data that can support operational decisions, reporting, analytics and AI initiatives.

Core responsabilities.

Pharma and life science picture 2

Data governance and compliance by design

  • Data strategy and governance: Align data initiatives with business, scientific and operational priorities.
  • Clear ownership and accountability: Define roles for data owners, data stewards and domain experts.
  • Data quality management: Establish rules, controls and monitoring processes for critical information.
  • Traceability and lineage: Improve visibility into data origins, transformations and usage.
  • Compliance by design: Embed governance and quality controls into everyday data processes.

Our Approach.

pharma and life science sectorial picture 1

From data strategy to sustainable adoption

APGAR supports pharma and life sciences organizations throughout their data transformation journey, from initial assessment to deployment and continuous improvement.

Our approach combines industry understanding, data expertise and technology capabilities to deliver solutions aligned with each organization’s priorities, existing systems and level of data maturity.

We help organizations:

  • Assess their data landscape and identify priority domains.
  • Define a pragmatic Data and AI roadmap.
  • Establish governance, ownership and quality standards.
  • Design scalable data architectures and operating models.
  • Select and implement adapted technologies.
  • Support adoption through training and change management.
  • Monitor results and continuously improve data practices.

APGAR’s internal positioning combines advisory, implementation, change management, managed services and training to support data transformation.

Turning trusted data into measurable business value.

Business Impact

Organizations supported by APGAR can build the foundations needed to achieve:

  • Higher data quality and consistency across business and scientific systems.
  • Stronger governance and accountability for critical data domains.
  • Improved traceability throughout data processes and transformations.
  • More efficient operations through reduced duplication and manual reconciliation.
  • Faster access to trusted information for research, manufacturing and commercial teams.
  • Scalable foundations for analytics and AI based on governed and reusable data.
  • Better collaboration between business, scientific, data and technology teams.

Our Pharma and Life Sciences Experience

APGAR brings together Data Management, Data Governance, Master Data Management, architecture and AI expertise to address the specific challenges of pharmaceutical and life sciences organizations.

Our sector experience includes work with organizations such as Novartis, Sandoz, IPSEN and Servier. Internal APGAR materials also mention support for healthcare organizations around data governance and regulatory compliance.

We apply proven methodologies while adapting governance, architecture and implementation choices to the organization’s operating model, business priorities and regulatory environment.

Transform life sciences data into trusted intelligence

Build a reliable and governed data foundation to support scientific innovation, operational performance and responsible AI.